TGFB1 and Duchenne muscular dystrophy: Furthermore, TP antagonism improved cardiac output, increased ejection fraction while decreasing cardiac fibrosis and transforming growth factor (TGF)−β signaling in mouse models of Duchenne muscular dystrophy (DMD) (26).